|
- 2019
Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndromeDOI: 10.1186/s12969-019-0322-9 Keywords: Autoinflammation, CANDLE syndrome, Immunoproteasome, JAK inhibitors, Nephrolithiasis Abstract: The patient: a. When he is 2?years 10?months old; b. When he is 5?years old, just before the start of baricitinib; c. After 7?months of treatment with baricitini
|